Bacteremia with streptococcus pneumoniae: Implications for therapy and prevention

JAMA

Volumn 275, Issue 3, 1996, Pages 194-198

  Plouffe, Joseph F ^a   Breiman, Robert F ^b   Facklam, Richard R ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; COTRIMOXAZOLE; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; DRUG INDICATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SEROTYPING; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0030060343     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.3.194     Document Type: Article

References (31)

1. Immunization Practices Advisory Committee. Update: pneumococcal polysaceharide vaccine usage - United States. MMWR Morb Mortal Wkly Rep. 1984;33:273-276, 281.
2. Research Committee of the British Thoracic Society and the Public Health Laboratory Service. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. Q J Med. 1987;62:195-220.
3. Woodhead MA, MacFarlane JT. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987;146:671-674.
4. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: a five year prospective study. Rev Infect Dis. 1989;11: 586-589.
5. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine (Baltimore). 1990;69:307-316.
6. Marston BJ, Plouffe JF, Breiman RF, et al. Preliminary finding of a community-based pneumonia incidence study. In: Barbaree JM, Breiman RF, Dufour AP, eds. Legionella: Current Status and Emerging Perspectives. Washington, DC: American Society for Microbiology; 1993:36-37.
7. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity and treatment. Clin Infect Dis. 1992;14: 801-807.
8. Schappert SM. Office Visits for Otitis Media: United States, 1975-90. Hyattsville, Md: US Dept of Health and Human Services, Public Health Service, CDC; 1992. Advance Data No. 214.
9. Friedland IR, McCracken GH. Management of infections caused by antibiotic resistant Streptococcus pneumaniae. N Engl J Med. 1994;331:377-382
10. Caputo GM, Appelbaum PC, Liu HH. Infections due to penicillin-resistant pneumococci. Arch Intern Med. 1993;103:1301-1310.
11. Plouffe JF, Moore SK, Davis R, Facklam RR. Serotypes of Streptococcus pneumoniae blood culture isolates from adults in Franklin County, Ohio. J Clin Microbiol. 1994;32:1606-1607.
12. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA. 1994;271:1831-1835.
13. Broome CV, Facklam RR. Epidemiology of clinically significant isolates of Streptococcus pnuemonaie in the United States. Rev Infect Dis. 1981; 3:277-281.
14. Jorgensen JH, Howell AW, Maher LA, Facklam RR. Serotypes of respiratory isolates of Streptococcus pneumoniae compared with capsular types included in the current pneumococcal vaccine. J Infect Dis 1991;163:644-646.
15. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Testa for Bacteria That Grow Aerobically 3rd ed. Approved standard M7-A3. Villanova, Pa: National Committee for Laboratory Standards; 1994.
16. Centers for Disease Control and Prevention. Pneumococcal polysaccharide vaccine. MMWR Morb Mortal Wkly Rep. 1989;38:64-76.
17. Greenland S, Robbins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics. 1985;41:55-68.
18. Appelbaum PC. World-wide development of antibiotic resistance in pneumococci. Eur J Clin Microbiol. 1987;6:367-377.
19. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med. 1995;333:474-480.
20. Centers for Disease Control and Prevention. Drug-resistant Streptococcus pneumoniae - Kentucky and Tennessee, 1993. MMWR Morb Mortal Wkly Rep. 1994,43:23-25, 31.
21. Centers for Disease Control and Prevention. Prevalence of penicillin-resistant Streptococcus pneumoniae - Connecticut, 1992-1993. MMWR Morb Mortal Wkly Rep. 1994;43:216-217, 223.
22. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med. 1995;333:481-486.
23. Naraqi S, Kirkpatrick GP, Kabins S. Relapsing pneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin G. J Pediatr. 1974;85:671-673.
24. American Thoracic Society. Guidelines for the initial management of adults with community acquired pneumonia:diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis. 1993;148:1418-1426.
25. Breiman RF, Spika FS, Navarro VJ, et al. Pneumococcal bacteremia in Charleston County: a decade later. Arch Intern Med. 1990;150:1401-1405.
26. Bennett NM, Buffington J, Laforce FM. Pneumococcal bacteremia in Monroe County, New York. Am J Public Health. 1992;82:1513-1516.
27. Plouffe JF, File TM, Breiman RF. Who receives pneumococcal vaccine (and who doesn't): Franklin and Summit Counties. In: Program of the 94th General Meeting of the American Society for Microbiology; May 24, 1994; Las Vegas, Nev.
28. Centers for Disease Control and Prevention. Race-specific differences in influenza vaccination levels among Medicare beneficiaries - United States, 1993. MMWR Morb Mortal Wkly Rep. 1996; 44:24-27, 33.
29. Douglas RM, Sturt J. Penicillin-resistant pneumococci and pneumonia. Med J Aust. 1970;1:82-83.
30. Munoz R, Coffey TJ, Daniels CG, et al. Intercontinental spread of a multiresistant done of serotyoe 23F Streptococcus pneumoniae. J Infect Dis. 1991;164:302-306.
31. Klugman KP. Pneumococcal resistance and antibiotics. Clin Microbiol Rev. 1990;3:171-196.